Details for New Drug Application (NDA): 204203
✉ Email this page to a colleague
The generic ingredient in QUETIAPINE FUMARATE is quetiapine fumarate. There are fifty-three drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the quetiapine fumarate profile page.
Summary for 204203
Tradename: | QUETIAPINE FUMARATE |
Applicant: | Lupin Ltd |
Ingredient: | quetiapine fumarate |
Patents: | 0 |
Suppliers and Packaging for NDA: 204203
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
QUETIAPINE FUMARATE | quetiapine fumarate | TABLET, EXTENDED RELEASE;ORAL | 204203 | ANDA | Major Pharmaceuticals | 0904-6801 | 0904-6801-61 | 100 BLISTER PACK in 1 CARTON (0904-6801-61) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
QUETIAPINE FUMARATE | quetiapine fumarate | TABLET, EXTENDED RELEASE;ORAL | 204203 | ANDA | Major Pharmaceuticals | 0904-6802 | 0904-6802-61 | 100 BLISTER PACK in 1 CARTON (0904-6802-61) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 50MG BASE | ||||
Approval Date: | May 17, 2017 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 150MG BASE | ||||
Approval Date: | May 17, 2017 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 200MG BASE | ||||
Approval Date: | May 17, 2017 | TE: | AB | RLD: | No |
Complete Access Available with Subscription